1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. HARPOON THERAPEUTICS INC

Harpoon Therapeutics Inc

XNAS: HARP

Momentum Trap

Watchlist

Portfolio

Share


Insider Trading disclosures for Harpoon Therapeutics Inc

The latest disclosure was made by Luke Nathaniel Walker in Harpoon Therapeutics Inc where a trade of 115,000 Common Stock done was reported to US exchanges on Jan. 7, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Luke Nathaniel Walker Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2024 115,000 135,000 (0%) 0% 0 Common Stock
Eastland Julie Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2024 178,500 232,003 (0%) 0% 0 Common Stock
Lanza Frank Principal Fin. & Acctng Ofc. Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2024 15,000 18,362 (0%) 0% 0 Common Stock
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 1,072 12,801 (0%) 0% 0 Common Stock
D. Myers Scott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 2,048 22,666 (0%) 0% 0 Common Stock
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 1,072 12,801 (0%) 0% 0 Common Stock
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 35,634 98,215 (0%) 0% 0 Common Stock
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 18,656 36,941 (0%) 0% 0 Common Stock
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 18,656 36,941 (0%) 0% 0 Common Stock
Lauren P. Silvernail Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 46,000 46,000 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Andrews R. Robbins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Joseph S. Bailes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 23,000 23,000 - - Director Stock Option (Right to Buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 34,925 62,581 (0%) 0% 0 Common Stock
Alan B. Colowick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 16,456 16,456 (0%) 0% 0 Common Stock
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 18,285 18,285 (0%) 0% 0 Common Stock
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 18,285 18,285 (0%) 0% 0 Common Stock
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2023 21,028 21,028 (0%) 0% 0 Common Stock
Ronald M. Hunt Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Mar 2023 2,994,305 2,994,305 - - Common Stock Warrant (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1000.00 per share. 23 Mar 2023 10,000 10,000 - 1000 10,000,000 8.000% Series A Redeemable Preferred Stock
Julie Eastland Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 407,600 407,600 - - Employee Stock Option (right to buy)
Frank Lanza Principal Fin. & Acctng Ofc. Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 65,000 65,000 - - Employee Stock Option (right to buy)
Frank Lanza Principal Fin. & Acctng Ofc. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Nov 2022 86,438 86,438 - - Employee Stock Option (right to buy)
Lauren P. Silvernail Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 20,335 20,335 - - Director Stock Option (right to buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 20,334 20,334 - - Director Stock Option (Right to Buy)
Alan B. Colowick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,571 28,571 - - Director Stock Option (Right to Buy)
Alan B. Colowick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 32,142 32,142 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Andrews R. Robbins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 32,142 32,142 - - Director Stock Option (Right to Buy)
Joseph S. Bailes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 31,428 31,428 - - Director Stock Option (Right to Buy)
Joseph S. Bailes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 10,167 10,167 - - Director Stock Option (Right to Buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 37,500 37,500 - - Director Stock Option (Right to Buy)
Georgia L. Erbez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 115,000 115,000 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 155,000 155,000 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 135,000 135,000 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2021 115,000 115,000 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2021 155,000 155,000 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2021 135,000 135,000 - - Employee Stock Option (right to buy)
Julie Eastland Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2021 350,000 350,000 - - Stock Option (Right to Buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2021 10,167 10,167 - - Director Stock Option (Right to Buy)
Georgia L. Erbez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 8.10 per share. 22 Sep 2021 10,300 19,215 (0%) 0% 8.1 83,430 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.00 per share. 01 Jul 2021 10,000 52,852 (0%) 0% 14 140,000 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 10,000 21,002 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 01 Jul 2021 10,000 62,852 (0%) 0% 0.6 6,000 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 20.41 per share. 01 Apr 2021 9,500 53,352 (0%) 0% 20.4 193,921 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 01 Apr 2021 8,466 61,318 (0%) 0% 0.6 5,080 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 01 Apr 2021 1,534 62,852 (0%) 0% 0.6 920 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 21.14 per share. 01 Apr 2021 500 52,852 (0%) 0% 21.1 10,570 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2021 8,466 2,540 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2021 1,534 31,002 - - Employee Stock Option (right to buy)
Alan B. Colowick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2021 20,335 20,335 - - Director Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Feb 2021 25,000 145,908 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 17 Feb 2021 25,000 72,292 (0%) 0% 2.1 53,000 Common Stock
Gerald McMahon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 181,470 181,470 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 72,000 72,000 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 80,000 80,000 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 52,000 52,000 - - Employee Stock Option (right to buy)
Ronald M. Hunt Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 11 Jan 2021 235,294 913,860 (3%) 0% 17 3,999,998 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 04 Jan 2021 10,000 62,852 (0%) 0% 0.6 6,000 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.30 per share. 04 Jan 2021 3,351 56,401 (0%) 0% 18.3 61,327 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 17.32 per share. 04 Jan 2021 3,100 59,752 (0%) 0% 17.3 53,683 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2021 10,000 11,006 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 19.39 per share. 04 Jan 2021 3,549 52,852 (0%) 0% 19.4 68,828 Common Stock
Georgia L. Erbez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.40 per share. 18 Aug 2020 5,000 8,915 (0%) 0% 11.4 57,000 Common Stock
Georgia L. Erbez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.60 per share. 18 Aug 2020 2,098 3,915 (0%) 0% 11.6 24,337 Common Stock
Georgia L. Erbez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 10.92 per share. 31 Jul 2020 1,817 1,817 (0%) 0% 10.9 19,842 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 01 Jul 2020 10,000 62,669 (0%) 0% 0.6 6,000 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2020 10,000 31,006 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 16.20 per share. 01 Jul 2020 10,000 52,669 (0%) 0% 16.2 161,989 Common Stock
Joanne Viney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 20,335 20,335 - - Director Stock Option (right to buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 3,587 3,587 - - Director Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Patrick A. Baeuerle None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 2,584 2,584 - - Director Stock Option (Right to Buy)
Patrick A. Baeuerle None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Scott Myers None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 4,906 4,906 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Julie Eastland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 2,880 2,880 - - Director Stock Option (Right to Buy)
Mark Chin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 3,017 3,017 - - Director Stock Option (Right to Buy)
Mark Chin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 10,167 10,167 - - Director Stock Option (Right to Buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 18 May 2020 1,522 47,276 (0%) 0% 2.1 3,227 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2020 1,522 45,625 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.77 per share. 18 May 2020 1,522 45,754 (0%) 0% 14.8 22,479 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.09 per share. 12 May 2020 1,400 52,669 (0%) 0% 14.1 19,720 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 May 2020 1,400 41,006 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 12 May 2020 1,400 54,069 (0%) 0% 0.6 840 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2020 5,350 44,406 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2020 1,000 42,406 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2020 1,000 43,406 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.06 per share. 07 May 2020 1,000 52,669 (0%) 0% 14.1 14,065 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 07 May 2020 1,000 53,669 (0%) 0% 0.6 600 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.00 per share. 07 May 2020 1,000 52,669 (0%) 0% 14 14,000 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 07 May 2020 1,000 53,669 (0%) 0% 0.6 600 Common Stock
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.13 per share. 07 May 2020 5,350 52,669 (0%) 0% 14.1 75,576 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 07 May 2020 5,350 58,019 (0%) 0% 0.6 3,210 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 01 May 2020 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2020 5,826 168,926 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.07 per share. 01 May 2020 5,826 45,754 (0%) 0% 12.1 70,301 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2020 1,250 49,756 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.05 per share. 28 Apr 2020 1,250 52,669 (0%) 0% 14.1 17,565 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 28 Apr 2020 1,250 53,919 (0%) 0% 0.6 750 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2020 500 48,168 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 16 Apr 2020 500 46,254 (0%) 0% 2.1 1,060 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.00 per share. 16 Apr 2020 500 45,754 (0%) 0% 12 6,000 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 16 Apr 2020 1,021 46,775 (0%) 0% 2.1 2,165 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.08 per share. 16 Apr 2020 1,021 45,754 (0%) 0% 12.1 12,330 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2020 1,021 47,147 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 13 Apr 2020 4,556 50,310 (0%) 0% 2.1 9,659 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2020 4,556 174,752 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.06 per share. 13 Apr 2020 4,556 45,754 (0%) 0% 12.1 54,959 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.00 per share. 06 Apr 2020 570 45,754 (0%) 0% 12 6,840 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 06 Apr 2020 570 46,324 (0%) 0% 2.1 1,208 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 06 Apr 2020 700 46,454 (0%) 0% 2.1 1,484 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.00 per share. 06 Apr 2020 700 45,754 (0%) 0% 12.0 8,401 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2020 570 179,308 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2020 700 179,878 - - Employee Stock Option (right to buy)
Andrews R. Robbins None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 20,335 20,335 - - Director Stock Option (right to buy)
Joseph S. Bailes None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 20,335 20,335 - - Director Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.00 per share. 16 Mar 2020 1 45,754 (0%) 0% 12 12 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2020 1,520 48,668 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2020 1 50,188 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.00 per share. 16 Mar 2020 1,520 45,754 (0%) 0% 12 18,240 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 16 Mar 2020 1,520 47,274 (0%) 0% 2.1 3,222 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 16 Mar 2020 1 45,755 (0%) 0% 2 2 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 02 Mar 2020 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2020 5,826 180,578 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.68 per share. 02 Mar 2020 5,826 45,754 (0%) 0% 14.7 85,526 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2020 1,521 50,189 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 18 Feb 2020 1,521 45,754 (0%) 0% 15 22,815 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 18 Feb 2020 1,521 47,275 (0%) 0% 2.1 3,225 Common Stock
Gerald McMahon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 165,210 165,210 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 52,160 52,160 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 31 Jan 2020 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2020 5,826 186,404 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 75,440 75,440 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.90 per share. 31 Jan 2020 5,826 45,754 (0%) 0% 13.9 81,006 Common Stock
Holger Wesche Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 52,313 52,313 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 14.09 per share. 21 Jan 2020 6,700 6,700 (0%) 0% 14.1 94,418 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.94 per share. 16 Jan 2020 1,521 45,754 (0%) 0% 14.9 22,725 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2020 1,521 51,710 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 16 Jan 2020 1,521 47,275 (0%) 0% 2.1 3,225 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.18 per share. 02 Jan 2020 5,826 45,754 (0%) 0% 14.2 82,600 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2020 5,826 192,230 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 02 Jan 2020 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 02 Jan 2020 10,000 62,669 (0%) 0% 0.6 6,000 Common Stock
Holger Wesche Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2020 10,000 51,006 - - Employee Stock Option (right to buy)
Holger Wesche Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 14.40 per share. 02 Jan 2020 10,000 52,669 (0%) 0% 14.4 143,987 Common Stock
Patrick A. Baeuerle None Sale of securities on an exchange or to another person at price $ 18.07 per share. 27 Dec 2019 1,400 262,136 (1%) 0% 18.1 25,297 Common Stock
Patrick A. Baeuerle None Sale of securities on an exchange or to another person at price $ 16.90 per share. 27 Dec 2019 10,417 263,536 (1%) 0% 16.9 176,062 Common Stock
Patrick A. Baeuerle None Sale of securities on an exchange or to another person at price $ 15.81 per share. 27 Dec 2019 75,562 273,953 (1%) 0% 15.8 1,194,922 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 16 Dec 2019 1,521 47,275 (0%) 0% 2.1 3,225 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2019 1,521 53,231 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.02 per share. 16 Dec 2019 1,521 45,754 (0%) 0% 17.0 25,888 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 17.02 per share. 13 Dec 2019 13,080 2,584,835 (10%) 0% 17.0 222,680 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 16.83 per share. 13 Dec 2019 12,476 2,572,359 (10%) 0% 16.8 209,969 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 17.21 per share. 13 Dec 2019 11,002 2,597,915 (10%) 0% 17.2 189,341 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 18.30 per share. 06 Dec 2019 26,438 2,817,929 (11%) 0% 18.3 483,781 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 16.91 per share. 06 Dec 2019 131,696 2,608,917 (10%) 0% 16.9 2,227,019 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 18.12 per share. 06 Dec 2019 77,316 2,740,613 (11%) 0% 18.1 1,400,664 Common Stock
Mark Chin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 19.15 per share. 06 Dec 2019 47,752 2,844,367 (11%) 0% 19.1 914,222 Common Stock
Georgia L. Erbez Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2019 47,292 170,908 - - Employee Stock Option (right to buy)
Georgia L. Erbez Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 04 Dec 2019 47,292 47,292 (0%) 0% 2.1 100,259 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.98 per share. 02 Dec 2019 5,826 45,754 (0%) 0% 18.0 104,751 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Dec 2019 5,826 198,056 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 02 Dec 2019 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.33 per share. 18 Nov 2019 17,252 46,754 (0%) 0% 13.3 229,964 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2019 18,252 54,752 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.00 per share. 18 Nov 2019 1,000 45,754 (0%) 0% 14 14,000 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 18 Nov 2019 18,252 64,006 (0%) 0% 2.1 38,694 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 01 Nov 2019 5,826 51,580 (0%) 0% 2.1 12,351 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2019 5,826 203,882 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.17 per share. 01 Nov 2019 5,826 45,754 (0%) 0% 13.2 76,702 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.21 per share. 14 Oct 2019 11,698 45,754 (0%) 0% 13.2 154,481 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 14 Oct 2019 11,698 57,452 (0%) 0% 2.1 24,800 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. 14 Oct 2019 12,452 58,206 (0%) 0% 2.1 26,398 Common Stock
Natalie Sacks Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.27 per share. 14 Oct 2019 12,452 45,754 (0%) 0% 13.3 165,280 Common Stock
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Oct 2019 11,698 209,708 - - Employee Stock Option (right to buy)
Natalie Sacks Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Oct 2019 12,452 221,406 - - Employee Stock Option (right to buy)
Gerald McMahon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2019 169,462 318,590 - - Employee Stock Option (right to buy)
Gerald McMahon Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 05 Jun 2019 169,462 172,462 (0%) 0% 0.6 101,677 Common Stock
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Patrick A. Baeuerle None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Julie Eastland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Mark Chin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2019 10,167 10,167 - - Director Stock Option (Right to Buy)
Gerald McMahon Director, President and CEO Purchase of securities on an exchange or from another person at price $ 10.16 per share. 14 May 2019 1,000 3,000 (0%) 0% 10.2 10,157 Common Stock
Gerald McMahon Director, President and CEO Purchase of securities on an exchange or from another person at price $ 10.56 per share. 08 May 2019 1,000 2,000 (0%) 0% 10.6 10,559 Common Stock
Gerald McMahon Director, President and CEO Purchase of securities on an exchange or from another person at price $ 10.53 per share. 03 May 2019 1,000 1,000 (0%) 0% 10.5 10,530 Common Stock
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 7,658 7,658 - - Director Stock Option (Right to Buy)
Patrick A. Baeuerle None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 3,829 3,829 - - Director Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 4,923 4,923 - - Director Stock Option (Right to Buy)
Julie Eastland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 5,907 5,907 - - Director Stock Option (Right to Buy)
Jonathan G. Drachman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 4,266 4,266 - - Director Stock Option (Right to Buy)
Mark Chin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2019 6,071 6,071 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters